{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:05:44Z","timestamp":1759482344275},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1038\/ncpneph0253","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T15:18:05Z","timestamp":1156951085000},"page":"514-526","source":"Crossref","is-referenced-by-count":13,"title":["Therapy Insight: management of cardiovascular disease in the renal transplant recipient"],"prefix":"10.1038","volume":"2","author":[{"given":"Claudio","family":"Rigatto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Parfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpneph0253_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0002-9343(88)90302-6","volume":"84","author":"BL Kasiske","year":"1988","unstructured":"Kasiske BL (1988) Risk factors for accelerated atherosclerosis in renal transplant patients. Am J Med 84: 985\u2013992","journal-title":"Am J Med"},{"key":"BFncpneph0253_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00007890-199509000-00008","volume":"60","author":"A Lindholm","year":"1995","unstructured":"Lindholm A et al. (1995) Ischemic heart disease\u2014major cause of death and graft loss after transplantation in Scandinavia. Transplantation 60: 451\u2013457","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"BFncpneph0253_CR3","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN et al. (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl 3): S112\u2013S119","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR4","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","volume":"56","author":"BF Culleton","year":"1999","unstructured":"Culleton BF et al. (1999) Cardiovascular disease and mortality in a community based cohort with mild renal insufficiency. Kidney Int 56: 2214\u20132219","journal-title":"Kidney Int"},{"key":"BFncpneph0253_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","volume":"27","author":"A Levin","year":"1996","unstructured":"Levin A et al. (1996) Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27: 347\u2013354","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/ajkd.2001.22070","volume":"37","author":"M Tonelli","year":"2001","unstructured":"Tonelli M et al. (2001) Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 37: 484\u2013489","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00007890-200008270-00006","volume":"70","author":"C Rigatto","year":"2000","unstructured":"Rigatto C et al. (2000) Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 70: 570\u2013575","journal-title":"Transplantation"},{"key":"BFncpneph0253_CR8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","volume":"13","author":"C Rigatto","year":"2002","unstructured":"Rigatto C et al. (2002) Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13: 1084\u20131090","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","volume":"14","author":"C Rigatto","year":"2003","unstructured":"Rigatto C et al. (2003) Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14: 462\u2013468","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ki.1995.22","volume":"47","author":"R Foley","year":"1995","unstructured":"Foley R et al. (1995) Clinical and echocardiographic disease in end-stage renal disease: prevalence, associations, and risk factors. Kidney Int 47: 186\u2013192","journal-title":"Kidney Int"},{"key":"BFncpneph0253_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000185077","volume":"49","author":"J Huting","year":"1988","unstructured":"Huting J et al. (1988) Analysis of left ventricular changes associated with chronic hemodialysis: a non-invasive follow-up study. Nephron 49: 284\u2013290","journal-title":"Nephron"},{"key":"BFncpneph0253_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/00007890-199511000-00005","volume":"60","author":"PS Parfrey","year":"1995","unstructured":"Parfrey PS et al. (1995) Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60: 908\u2013914","journal-title":"Transplantation"},{"key":"BFncpneph0253_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1097\/00007890-200212150-00016","volume":"74","author":"SR Ferreira","year":"2002","unstructured":"Ferreira SR et al. (2002) Cardiovascular effects of successful renal transplantation; a one year sequential study of left ventricular morphology and function, and 24 hour blood pressure profile. Transplantation 74: 1580\u20131587","journal-title":"Transplantation"},{"key":"BFncpneph0253_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","volume":"45","author":"RK Wali","year":"2005","unstructured":"Wali RK et al. (2005) Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 45: 1051\u20131060","journal-title":"J Am Coll Cardiol"},{"key":"BFncpneph0253_CR15","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1097\/01.ASN.0000083008.25305.67","volume":"14","author":"KC Abbott","year":"2003","unstructured":"Abbott KC et al. (2003) Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 14: 2358\u20132365","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","volume":"7","author":"BL Kasiske","year":"1996","unstructured":"Kasiske BL et al. (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7: 158\u2013165","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archinte.159.1.29","volume":"159","author":"M Senni","year":"1999","unstructured":"Senni M et al. (1999) Congestive heart failure in the community: trends in incidence and survival in a 10 year period. Arch Intern Med 159: 29\u201334","journal-title":"Arch Intern Med"},{"key":"BFncpneph0253_CR18","doi-asserted-by":"publisher","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","volume":"22","author":"K Ho","year":"1993","unstructured":"Ho K et al. (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22: 6A\u201313A","journal-title":"J Am Coll Cardiol"},{"key":"BFncpneph0253_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0735-1097(88)90454-8","volume":"12","author":"RB Himelman","year":"1988","unstructured":"Himelman RB et al. (1988) Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 12: 915\u2013923","journal-title":"J Am Coll Cardiol"},{"key":"BFncpneph0253_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/oxfordjournals.eurheartj.a062140","volume":"7","author":"O Larsson","year":"1986","unstructured":"Larsson O et al. (1986) Left ventricular function before and after kidney transplantation: a prospective study in patients with juvenile-onset diabetes mellitus. Eur Heart J 7: 779\u2013791","journal-title":"Eur Heart J"},{"key":"BFncpneph0253_CR21","first-page":"185","volume":"21","author":"A Deligiannis","year":"1985","unstructured":"Deligiannis A et al. (1985) Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 185\u2013189","journal-title":"Proc Eur Dial Transplant Assoc Eur Ren Assoc"},{"key":"BFncpneph0253_CR22","first-page":"74","volume":"18","author":"KN Lai","year":"1982","unstructured":"Lai KN et al. (1982) Effect of renal transplantation on left ventricular function in hemodialysis patients. Clin Nephrol 18: 74\u201378","journal-title":"Clin Nephrol"},{"key":"BFncpneph0253_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/hrt.47.2.155","volume":"47","author":"M Ikaheimo","year":"1982","unstructured":"Ikaheimo M et al. (1982) Effects of renal transplantation on left ventricular size and function. Br Heart J 47: 155\u2013160","journal-title":"Br Heart J"},{"key":"BFncpneph0253_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/0002-9149(92)90303-G","volume":"70","author":"J Huting","year":"1992","unstructured":"Huting J (1992) Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 70: 1481\u20131484","journal-title":"Am J Cardiol"},{"key":"BFncpneph0253_CR25","first-page":"497","volume":"10","author":"S Torres","year":"1991","unstructured":"Torres S et al. (1991) Morphologic course of the left ventricle after renal transplantation: echocardiographic study [Portuguese]. Rev Port Cardiol 10: 497\u2013501","journal-title":"Rev Port Cardiol"},{"key":"BFncpneph0253_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000176695","volume":"85","author":"J Peteiro","year":"1994","unstructured":"Peteiro J et al. (1994) Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study. Cardiology 85: 273\u2013283","journal-title":"Cardiology"},{"key":"BFncpneph0253_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","volume":"72","author":"K Midtvedt","year":"2001","unstructured":"Midtvedt K et al. (2001) Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation 72: 107\u2013111","journal-title":"Transplantation"},{"key":"BFncpneph0253_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","volume":"34","author":"A Levin","year":"1999","unstructured":"Levin A et al. (1999) Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34: 125\u2013134","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1681\/ASN.V75728","volume":"7","author":"RN Foley","year":"1996","unstructured":"Foley RN et al. (1996) Hypoalbuminemia, cardiac morbidity and mortality in end stage renal disease. J Am Soc Nephrol 7: 728\u2013736","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/oso\/9780192629876.003.0007","volume-title":"Cardiovascular Disease in End-Stage Renal Failure","author":"C Rigatto","year":"2000","unstructured":"Rigatto C et al. (2000) Cardiac hypertrophy in end-stage renal failure. In Cardiovascular Disease in End-Stage Renal Failure, 157\u2013175 (Eds Loscalzo J and London G) Oxford: Oxford University Press"},{"key":"BFncpneph0253_CR31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V111134","volume":"11","author":"D Ducloux","year":"2000","unstructured":"Ducloux D et al. (2000) Serum total homocysteine and cardiovascular disease occurrence in chronic stable transplant recipients: a prospective study. J Am Soc Nephrol 11: 134\u2013137","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.ajkd.2005.05.014","volume":"46","author":"AG Jardine","year":"2005","unstructured":"Jardine AG et al. (2005) Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis 46: 529\u2013536","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1681\/ASN.2004070580","volume":"16","author":"KL Lentine","year":"2005","unstructured":"Lentine KL et al. (2005) Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 16: 496\u2013506","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR34","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0041-1345(98)00531-4","volume":"30","author":"S Aker","year":"1998","unstructured":"Aker S et al. (1998) Cardiovascular complications after renal transplantation. Transplant Proc 30: 2039\u20132042","journal-title":"Transplant Proc"},{"key":"BFncpneph0253_CR35","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","volume":"11","author":"B Kasiske","year":"2000","unstructured":"Kasiske B et al. (2000) Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11: 1735\u20131743","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1523-1755.2004.00751.x","volume":"66","author":"D Ducloux","year":"2004","unstructured":"Ducloux D et al. (2004) Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 66: 441\u2013447","journal-title":"Kidney Int"},{"key":"BFncpneph0253_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/jama.283.5.633","volume":"283","author":"K Mange","year":"2000","unstructured":"Mange K et al. (2000) Arterial hypertension and renal allograft survival. JAMA 283: 633\u2013638","journal-title":"JAMA"},{"key":"BFncpneph0253_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","volume":"53","author":"G Opelz","year":"1998","unstructured":"Opelz G et al. (1998) Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 53: 217\u2013222","journal-title":"Kidney Int"},{"key":"BFncpneph0253_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","volume":"43","author":"BL Kasiske","year":"2004","unstructured":"Kasiske BL et al. (2004) Hypertension after kidney transplantation. Am J Kidney Dis 43: 1071\u20131081","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR40","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","volume":"344","author":"P Ridker","year":"2001","unstructured":"Ridker P et al. (2001) Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959\u20131965","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR41","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1097\/01.TP.0000160764.35083.B8","volume":"79","author":"B Fellstrom","year":"2005","unstructured":"Fellstrom B et al. (2005) Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial. Transplantation 79: 1160\u20131163","journal-title":"Transplantation"},{"key":"BFncpneph0253_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","volume":"3","author":"BL Kasiske","year":"2003","unstructured":"Kasiske BL et al. (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178\u2013185","journal-title":"Am J Transplant"},{"key":"BFncpneph0253_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"J Eikelboom","year":"1999","unstructured":"Eikelboom J et al. (1999) Homocysteine and cardiovascular disease: a critical review of the epidemiological evidence. Ann Intern Med 131: 363\u2013375","journal-title":"Ann Intern Med"},{"key":"BFncpneph0253_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7326\/0003-4819-131-5-199909070-00006","volume":"131","author":"A Bostom","year":"1999","unstructured":"Bostom A et al. (1999) Non-fasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 131: 352\u2013355","journal-title":"Ann Intern Med"},{"key":"BFncpneph0253_CR45","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1034\/j.1600-6143.2002.20404.x","volume":"2","author":"AN Friedman","year":"2002","unstructured":"Friedman AN et al. (2002) Hyperhomocysteinemia in renal transplant recipients. Am J Transplant 2: 308\u2013313","journal-title":"Am J Transplant"},{"key":"BFncpneph0253_CR46","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","volume":"361","author":"H Holdaas","year":"2003","unstructured":"Holdaas H et al.; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2003)Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361: 2024\u20132031","journal-title":"Lancet"},{"key":"BFncpneph0253_CR47","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1600-6143.2004.00445.x","volume":"4","author":"AG Jardine","year":"2004","unstructured":"Jardine AG et al.; ALERT Study Investigators (2004) Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. Am J Transplant 4: 988\u2013995","journal-title":"Am J Transplant"},{"issue":"Suppl 7","key":"BFncpneph0253_CR48","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1111\/j.1600-6135.2004.0355.x","volume":"4","author":"B Kasiske","year":"2004","unstructured":"Kasiske B et al. (2004) National Kidney Foundation: clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4 (Suppl 7): S13\u2013S53","journal-title":"Am J Transplant"},{"key":"BFncpneph0253_CR49","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 157: 2413\u20132446","DOI":"10.1001\/archinte.1997.00440420033005"},{"issue":"Suppl 3","key":"BFncpneph0253_CR50","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1053\/ajkd.1998.v32.pm9820471","volume":"32","author":"L Mailloux","year":"1998","unstructured":"Mailloux L and Levey A (1998) Hypertension in patients with chronic renal disease. Am J Kidney Dis 32 (Suppl 3): S120\u2013S141","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR51","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199403313301301","volume":"330","author":"S Klahr","year":"1994","unstructured":"Klahr S et al. (1994) The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disaese. N Engl J Med 330: 877\u2013884","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR52","doi-asserted-by":"publisher","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","volume":"123","author":"J Peterson","year":"1995","unstructured":"Peterson J et al. (1995) Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med 123: 754\u2013762","journal-title":"Ann Intern Med"},{"key":"BFncpneph0253_CR53","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L et al.; HOT Study Group (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351: 1755\u20131762","journal-title":"Lancet"},{"key":"BFncpneph0253_CR54","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206\u20131252","journal-title":"Hypertension"},{"key":"BFncpneph0253_CR55","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis EJ et al. (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456\u20131461","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR56","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/0140-6736(92)92889-N","volume":"340","author":"S Yusuf","year":"1992","unstructured":"Yusuf S et al. (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340: 1173\u20131178","journal-title":"Lancet"},{"key":"BFncpneph0253_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"E Lewis","year":"2001","unstructured":"Lewis E et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851\u2013860","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR58","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","volume":"359","author":"L Lindholm","year":"2002","unstructured":"Lindholm L et al. (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 1004\u20131010","journal-title":"Lancet"},{"key":"BFncpneph0253_CR59","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","volume":"355","author":"B Pitt","year":"2000","unstructured":"Pitt B et al. (2000) Effects of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial the Losartan Heart Failure Survival Study. Lancet 355: 1582\u20131587","journal-title":"Lancet"},{"key":"BFncpneph0253_CR60","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","volume":"360","author":"K Dickstein","year":"2002","unstructured":"Dickstein K and Kjekshus J (2002) Effects of losartan and captopril on mortality and morbidity in high risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Lancet 360: 752\u2013760","journal-title":"Lancet"},{"key":"BFncpneph0253_CR61","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"J Cohn","year":"2001","unstructured":"Cohn J and Tognoni G (2001) A randomized trial of the angiotensin receptor blocker valsartan in chronic heart failure. N Engl J Med 345: 1667\u20131675","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","volume":"361","author":"N Nakao","year":"2003","unstructured":"Nakao N et al. (2003) Combination therapy of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361: 117\u2013124","journal-title":"Lancet"},{"key":"BFncpneph0253_CR63","doi-asserted-by":"publisher","first-page":"707","DOI":"10.7326\/0003-4819-134-8-200104170-00007","volume":"134","author":"J Mann","year":"2001","unstructured":"Mann J et al. (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134: 707\u2013709","journal-title":"Ann Intern Med"},{"issue":"Suppl 7","key":"BFncpneph0253_CR64","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1097\/00005344-199000167-00037","volume":"16","author":"PC Sizeland","year":"1990","unstructured":"Sizeland PC et al. (1990) Anemia and angiotensin-converting enzyme inhibition in renal transplant recipients. J Cardiovasc Pharmacol 16 (Suppl 7): S117\u2013S119","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFncpneph0253_CR65","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2125.1992.tb05644.x","volume":"34","author":"MC Pratt","year":"1992","unstructured":"Pratt MC et al. (1992) Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 34: 363\u2013365","journal-title":"Br J Clin Pharmacol"},{"key":"BFncpneph0253_CR66","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","volume":"3","author":"Y Vanrenterghem","year":"2003","unstructured":"Vanrenterghem Y et al. (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3: 835\u2013845","journal-title":"Am J Transplant"},{"key":"BFncpneph0253_CR67","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/01.ASN.0000125551.59739.2E","volume":"15","author":"WC Winkelmayer","year":"2004","unstructured":"Winkelmayer WC et al. (2004) Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol 15: 1347\u20131352","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR68","doi-asserted-by":"crossref","unstructured":"Antiplatelet Trialists Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy: I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308: 81\u2013106","DOI":"10.1136\/bmj.308.6921.81"},{"key":"BFncpneph0253_CR69","doi-asserted-by":"crossref","unstructured":"Antiplatelet Trialists' Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J (Clin Res Ed) 296: 320\u2013331","DOI":"10.1136\/bmj.296.6618.320"},{"key":"BFncpneph0253_CR70","doi-asserted-by":"publisher","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","volume":"137","author":"R Wright","year":"2002","unstructured":"Wright R et al. (2002) Acute myocardial infarction and renal dysfunction: a high risk combination. Ann Intern Med 137: 563\u2013570","journal-title":"Ann Intern Med"},{"key":"BFncpneph0253_CR71","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/clc.4960220905","volume":"22","author":"R Zusman","year":"1999","unstructured":"Zusman R et al. (1999) Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. Clin Cardiol 22: 559\u2013573","journal-title":"Clin Cardiol"},{"key":"BFncpneph0253_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","volume":"136","author":"M Hayden","year":"2002","unstructured":"Hayden M et al. (2002) Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136: 161\u2013172","journal-title":"Ann Intern Med"},{"key":"BFncpneph0253_CR73","first-page":"49","volume":"16","author":"C Matsumoto","year":"2003","unstructured":"Matsumoto C et al. (2003) Hospitalized gastrointestinal bleeding and procedures after renal transplantation in the United States. J Nephrol 16: 49\u201356","journal-title":"J Nephrol"},{"key":"BFncpneph0253_CR74","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0272-6386(03)00359-7","volume":"41","author":"FC Trespalacios","year":"2003","unstructured":"Trespalacios FC et al. (2003) Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 41: 1267\u20131277","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR75","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","volume":"148","author":"JG Cleland","year":"2004","unstructured":"Cleland JG et al. (2004) The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 148: 157\u2013164","journal-title":"Am Heart J"},{"key":"BFncpneph0253_CR76","unstructured":"ISIS Collaborative Group (1986) Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2: 57\u201366"},{"key":"BFncpneph0253_CR77","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJM199611283352207","volume":"335","author":"C Hennekens","year":"1996","unstructured":"Hennekens C et al. (1996) Adjunctive drug therapy of acute myocardial infarction\u2014evidence from clinical trials. N Engl J Med 335: 1660\u20131667","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR78","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.1993.03510130095038","volume":"270","author":"KK Teo","year":"1993","unstructured":"Teo KK et al. (1993) Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 270: 1589\u20131595","journal-title":"JAMA"},{"key":"BFncpneph0253_CR79","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M et al. (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344: 1651\u20131658","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR80","doi-asserted-by":"crossref","unstructured":"The CIBIS-II Study group (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353: 9\u201313","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"BFncpneph0253_CR81","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/j.ajkd.2005.07.043","volume":"46","author":"TM Keough-Ryan","year":"2005","unstructured":"Keough-Ryan TM et al. (2005) Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia. Am J Kidney Dis 46: 845\u2013855","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0253_CR82","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1001\/archinte.164.22.2465","volume":"164","author":"KC Abbott","year":"2004","unstructured":"Abbott KC et al. (2004) \u03b2-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality. Arch Intern Med 164: 2465\u20132471","journal-title":"Arch Intern Med"},{"key":"BFncpneph0253_CR83","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1046\/j.1523-1755.2002.00636.x","volume":"62","author":"R Foley","year":"2002","unstructured":"Foley R et al. (2002) Blood pressure and long term mortality in US hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 62: 1784\u20131790","journal-title":"Kidney Int"},{"key":"BFncpneph0253_CR84","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0002-9149(89)90462-1","volume":"64","author":"J Silberberg","year":"1989","unstructured":"Silberberg J et al. (1989) Role of anemia in the pathogenesis of left ventricular hypertrophy in end stage renal disease. Am J Cardiol 64: 222\u2013224","journal-title":"Am J Cardiol"},{"key":"BFncpneph0253_CR85","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ki.1989.192","volume":"36","author":"J Silberberg","year":"1989","unstructured":"Silberberg J et al. (1989) Impact of left ventricular hypertrophy on survival in end stage renal disease. Kidney Int 36: 286\u2013290","journal-title":"Kidney Int"},{"key":"BFncpneph0253_CR86","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2004121039","volume":"16","author":"PS Parfrey","year":"2005","unstructured":"Parfrey PS et al. for the Canadian European Study (2005) Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16: 2180\u20132189","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR87","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.1990.03440060071035","volume":"263","author":"R Evans","year":"1990","unstructured":"Evans R et al. for The Cooperative Multicenter EPO Clinical Trial Group (1990) The quality of life of hemodialysis patients treated with recombinant human erythropoietin. JAMA 263: 825\u2013830","journal-title":"JAMA"},{"key":"BFncpneph0253_CR88","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199808273390903","volume":"339","author":"A Besarab","year":"1998","unstructured":"Besarab A et al. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoietin. N Engl J Med 339: 584\u2013590","journal-title":"N Engl J Med"},{"key":"BFncpneph0253_CR89","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/01.ASN.0000102471.89084.8B","volume":"15","author":"SD Roger","year":"2004","unstructured":"Roger SD et al. (2004) Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. J Am Soc Nephrol 15: 148\u2013156","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0253_CR90","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1161\/01.CIR.0000129317.12580.68","volume":"109","author":"CA Herzog","year":"2004","unstructured":"Herzog CA et al. (2004) Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation 109: 2866\u20132871","journal-title":"Circulation"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0253","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T07:13:07Z","timestamp":1707203587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["BFncpneph0253"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0253","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}